Michael Mezher on Muck Rack

Michael Mezher

Verified
Long Beach
As seen in: Regulatory Focus, Regulatory Affairs Professionals Society, Endpoints News, Friends of Cancer Research
Managing Editor @RAPSorg, covering FDA, EMA, pharma, biotech & medical devices.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Recon: Makary’s fate as FDA commissioner up in the air; Roche to buy PathAI for $750M

|
By Michael Mezher Verified
| Regulatory Affairs Professionals Society
Recon: Makary’s fate as FDA commissioner up in the air; Roche to buy PathAI for $750M Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Open in Who Shared Issue with article?

Euro Convergence 2026: Facing transformation with community

|
By Michael Mezher Verified
| Regulatory Affairs Professionals Society
Euro Convergence 2026: Facing transformation with community The healthcare product landscape in Europe is undergoing significant transformation—from multiple legislative overhauls to the rapid adoption of artificial intelligence (AI) and other boundary-pushing technologies. For regulatory professionals attending RAPS Euro Convergence 2026 in Lisbon, the meeting is an opportunity to lean into community to stay on top of the myriad changes coming their way.
Open in Who Shared Issue with article?

Regulatory Focus - This Week at FDA: FDA names new Office of Compliance, CVM directors

|
By Michael Mezher Verified, Ferdous Al-Faruque, Joanne S. Eglovitch
| Friends of Cancer Research
Michael Mezher, Ferdous Al-Faruque, and Joanne S. Eglovitch Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, we learned that FDA has filled two leadership roles at the agency, and that it will host an upcoming patient-focused drug development (PFDD) meeting focused on long COVID.
Open in Who Shared Issue with article?
See all 927 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified